Cargando…

Maintenance Chemotherapy for Patients with Rhabdomyosarcoma

SIMPLE SUMMARY: The updated results of the RMS2005 randomized study confirm that patients with non-metastatic high risk rhabdomyosarcoma have an improved survival when maintenance chemotherapy (MC) with vinorelbine and low dose cyclophosphamide is added to the standard multidisciplinary treatment. A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bisogno, Gianni, Minard-Colin, Veronique, Jenney, Meriel., Ferrari, Andrea, Chisholm, Julia, Di Carlo, Daniela, Hjalgrim, Lisa Lyngsie, Orbach, Daniel, Merks, Johannes Hendrikus Maria, Casanova, Michela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417571/ https://www.ncbi.nlm.nih.gov/pubmed/37568826 http://dx.doi.org/10.3390/cancers15154012

Ejemplares similares

Biological Role and Clinical Implications of MYOD1(L122R) Mutation in Rhabdomyosarcoma
por: Di Carlo, Daniela, et al.
Publicado: (2023)

Patient Reported Outcomes and Measures in Children with Rhabdomyosarcoma
por: van Gorp, Marloes, et al.
Publicado: (2023)

Shedding a Light on the Challenges of Adolescents and Young Adults with Rhabdomyosarcoma
por: Ferrari, Andrea, et al.
Publicado: (2022)

Metastatic Rhabdomyosarcoma: Results of the European Paediatric Soft Tissue Sarcoma Study Group MTS 2008 Study and Pooled Analysis With the Concurrent BERNIE Study
por: Schoot, Reineke A., et al.
Publicado: (2022)

Local staging and treatment in extremity rhabdomyosarcoma. A report from the EpSSG‐RMS2005 study
por: Terwisscha van Scheltinga, Sheila E. J., et al.
Publicado: (2020)

Is surveillance imaging in pediatric patients treated for localized rhabdomyosarcoma useful? The European experience
por: Vaarwerk, Bas, et al.
Publicado: (2019)

Pediatric Non-Rhabdomyosarcoma Soft Tissue Sarcomas: Standard of Care and Treatment Recommendations from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG)
por: Ferrari, Andrea, et al.
Publicado: (2022)

Pediatric Rhabdomyosarcomas: Three-Dimensional Radiological Assessments after Induction Chemotherapy Predict Survival Better than One-Dimensional and Two-Dimensional Measurements
por: Orsatti, Giovanna, et al.
Publicado: (2020)

An emerging evidence base for PET-CT in the management of childhood rhabdomyosarcoma: systematic review
por: Norman, Gill, et al.
Publicado: (2015)

Quantitative diffusion-weighted MRI response assessment in rhabdomyosarcoma: an international retrospective study on behalf of the European paediatric Soft tissue sarcoma Study Group Imaging Committee
por: van Ewijk, Roelof, et al.
Publicado: (2023)

The Value of Early Tumor Size Response to Chemotherapy in Pediatric Rhabdomyosarcoma
por: van Ewijk, Roelof, et al.
Publicado: (2021)

MiRNAs as Players in Rhabdomyosarcoma Development
por: Gasparini, Patrizia, et al.
Publicado: (2019)

Anaplastic lymphoma kinase aberrations correlate with metastatic features in pediatric rhabdomyosarcoma
por: Gasparini, Patrizia, et al.
Publicado: (2016)

DAX-1 Expression in Pediatric Rhabdomyosarcomas: Another Immunohistochemical Marker Useful in the Diagnosis of Translocation Positive Alveolar Rhabdomyosarcoma
por: Virgone, Calogero, et al.
Publicado: (2015)

Clinical Insight on Proton Therapy for Paediatric Rhabdomyosarcoma
por: Vennarini, Sabina, et al.
Publicado: (2023)

Genomic complexity in pediatric synovial sarcomas (Synobio study): the European pediatric soft tissue sarcoma group (EpSSG) experience
por: Orbach, Daniel, et al.
Publicado: (2018)

Imaging findings in noncraniofacial childhood rhabdomyosarcoma
por: Van Rijn, Rick R., et al.
Publicado: (2008)

Circulating miR-26a as Potential Prognostic Biomarkers in Pediatric Rhabdomyosarcoma
por: Tombolan, Lucia, et al.
Publicado: (2020)

Treatment of Rhabdomyosarcoma in Children and Adolescent from Four Low Health Expenditures Average Rates Countries
por: Mazic, Maja Cesen, et al.
Publicado: (2020)

Prognostic Value of Circulating IGFBP2 and Related Autoantibodies in Children with Metastatic Rhabdomyosarcomas
por: Poli, Elena, et al.
Publicado: (2020)

Imaging findings in craniofacial childhood rhabdomyosarcoma
por: Freling, Nicole J. M., et al.
Publicado: (2010)

Development of an intravenous chemotherapy intervention for children and adolescents with cancer administered by their parents at home (INTACTatHome)
por: Roug, Louise Ingerslev, et al.
Publicado: (2023)

A Perspective on Polo-Like Kinase-1 Inhibition for the Treatment of Rhabdomyosarcomas
por: Gatz, Susanne A., et al.
Publicado: (2019)

Autoantibody profiling of alveolar rhabdomyosarcoma patients unveils tumor-associated antigens with diagnostic and prognostic significance
por: Poli, Elena, et al.
Publicado: (2021)

Clinical Characteristics, Treatment Considerations, and Outcomes of Infants with Rhabdomyosarcoma
por: Yan, Adam P., et al.
Publicado: (2023)

MicroRNA-27a Contributes to Rhabdomyosarcoma Cell Proliferation by Suppressing RARA and RXRA
por: Tombolan, Lucia, et al.
Publicado: (2015)

NELL1, whose high expression correlates with negative outcomes, has different methylation patterns in alveolar and embryonal rhabdomyosarcoma
por: Tombolan, Lucia, et al.
Publicado: (2017)

Integrative clinical and biopathology analyses to understand the clinical heterogeneity of infantile rhabdomyosarcoma: A report from the French MMT committee
por: Butel, Thibault, et al.
Publicado: (2020)

Clinical significance of circulating tumor cells and cell‐free DNA in pediatric rhabdomyosarcoma
por: Tombolan, Lucia, et al.
Publicado: (2022)

Immunoreactivity against fibroblast growth factor 8 in alveolar rhabdomyosarcoma patients and its involvement in tumor aggressiveness
por: Poli, Elena, et al.
Publicado: (2022)

Seasonality of main childhood embryonal tumours and rhabdomyosarcoma, France, 2000–2015
por: Awounou, Danielle, et al.
Publicado: (2023)

Hyper-Activation of Notch3 Amplifies the Proliferative Potential of Rhabdomyosarcoma Cells
por: De Salvo, Maria, et al.
Publicado: (2014)

Evaluation of clinical efficacy of Chemotherapy for Rhabdomyosarcoma in children
por: Ning, Zhaohui, et al.
Publicado: (2020)

Genomic Classification and Clinical Outcome in Rhabdomyosarcoma: A Report From an International Consortium
por: Shern, Jack F., et al.
Publicado: (2021)

PD-L1 assessment in pediatric rhabdomyosarcoma: a pilot study
por: Bertolini, Giulia, et al.
Publicado: (2018)

Locoregional Control and Survival in Children, Adolescents, and Young Adults With Localized Head and Neck Alveolar Rhabdomyosarcoma—The French Experience
por: Machavoine, Roxane, et al.
Publicado: (2022)

High ALK mRNA expression has a negative prognostic significance in rhabdomyosarcoma
por: Bonvini, P, et al.
Publicado: (2013)

Prostatic Stromal Sarcoma in an Adolescent: The Role of Chemotherapy
por: Cavaliere, Elena, et al.
Publicado: (2014)

Establishment of 6 pediatric rhabdomyosarcoma patient’s derived xenograft models closely recapitulating patients’ tumor characteristics
por: Gasparini, Patrizia, et al.
Publicado: (2022)

Imaging in rhabdomyosarcoma: a patient journey
por: de Vries, Isabelle S. A., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_e4ubp6vt4nqamjb2nf956du1ie